BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 33282585)

  • 1. Aberrant Partial Chromosomal Instability With Chemotherapeutically Resistant Metachronous Colorectal Cancer Following a Synchronous Primary Colorectal Cancer: A Case Report.
    Dominic JL; Feroz SH; Muralidharan A; Ahmed A; Thirunavukarasu P
    Cureus; 2020 Nov; 12(11):e11308. PubMed ID: 33282585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
    Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency.
    Nakano K; Yamamoto H; Fujiwara M; Koga Y; Tsuruta S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
    Am J Surg Pathol; 2018 Feb; 42(2):172-182. PubMed ID: 28877066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous and metachronous primary colorectal cancers with concordant and discordant mismatch repair status.
    Carlin L; Paudice M; Ingaliso M; Pigozzi S; Trevisan L; Sciallero S; Pastorino A; Piol N; Grillo F; Mastracci L
    Hum Pathol; 2023 Nov; 141():54-63. PubMed ID: 37742947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy.
    Aisu N; Yoshida Y; Ishii F; Miyake T; Tanimura S; Wada Y; Yamauchi Y; Hoshino S; Noritomi T; Yamashita Y
    Case Rep Oncol; 2013 Jan; 6(1):143-7. PubMed ID: 23569449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and molecular features between synchronous and metachronous metastases in colorectal cancer.
    Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
    Am J Cancer Res; 2021; 11(4):1646-1658. PubMed ID: 33948379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature.
    Zhang Y; Zhang F; Zhao L; Fu X; Shang Y; Gao Q
    BMC Gastroenterol; 2021 Oct; 21(1):399. PubMed ID: 34688262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases.
    Yoshida Y; Hoshino S; Miyake T; Fukuda S; Yamada K; Naoya A; Tanimura S; Yamashita Y
    Case Rep Oncol; 2012 May; 5(2):290-5. PubMed ID: 22740818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
    Tappenden P; Jones R; Paisley S; Carroll C
    Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
    Bennouna J; Hiret S; Bertaut A; Bouché O; Deplanque G; Borel C; François E; Conroy T; Ghiringhelli F; des Guetz G; Seitz JF; Artru P; Hebbar M; Stanbury T; Denis MG; Adenis A; Borg C
    JAMA Oncol; 2019 Jan; 5(1):83-90. PubMed ID: 30422156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer.
    Kim ST; Kim HK; Lee J; Park SH; Lim HY; Park YS; Kang WK; Park JO
    J Cancer; 2018; 9(10):1791-1796. PubMed ID: 29805705
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomatous Polyposis Coli, mismatch repair, and microsatellite instability in colorectal cancer based on different locations.
    Effendi-Y S R; Zain LH; Siregar GA; Lubis HR; Damanik HA; Laksmi LI; Chrestella J
    Acta Med Indones; 2013 Oct; 45(4):275-83. PubMed ID: 24448331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.